About
Silvia is an entrepreneur and leading executive with over 25 years of experience in the Biopharmaceuticals Industry. Before joining Pontifax, she was Founder and Senior Vice President at Predix Pharmaceuticals, bringing a small early-stage drug discovery company from inception to a $500M publicly traded company. At Predix, Silvia advanced four discovery programs to late-stage clinical trials and forged significant partnerships with top pharma players. Silvia founded and is a board member of many of the Pontifax’s portfolio companies, including: Eloxx Pharmaceuticals, where she assumes a CEO position, Quiet Therapeutics, where she is Chairwoman of the Board and cCAM Biotherapeutics where she held an Executive Chairwoman position. Silvia has a Ph.D. in Molecular Biology from Tel Aviv University and Post Doc from the Weizmann Institute of Science.
Investment Focus
- Location
- Israel
Contact Information
Find more investors like Silvia
Search Investors